| Q70189285 | A novel method for detecting the antiviral activity of flavans in their vapour phase |
| Q37263877 | A novel, broad-spectrum inhibitor of enterovirus replication that targets host cell factor phosphatidylinositol 4-kinase IIIβ. |
| Q35309733 | Activity against rhinoviruses, toxicity, and delivery in aerosol of enviroxime in liposomes |
| Q39498844 | Antiviral agents against picornaviruses. |
| Q30457345 | Antiviral chemotherapy and prophylaxis of viral respiratory disease |
| Q39309529 | Antiviral therapy with small particle aerosols |
| Q28369887 | Application of oral bioavailability surrogates in the design of orally active inhibitors of rhinovirus replication |
| Q93238473 | Chapter 12. Antiviral Agents |
| Q91901469 | Chapter 4 Picornavirus infections |
| Q30451740 | Chemotherapy of rhinovirus colds |
| Q68631792 | Chromatographic methods for the bioanalysis of antiviral agents |
| Q38363307 | Common colds. Causes, potential cures, and treatment |
| Q35569043 | Controlled trial of enviroxime against natural rhinovirus infections in a community |
| Q99711441 | Enterovirus Replication Organelles and Inhibitors of Their Formation |
| Q44949309 | Failure of oral 4′, 6-dichloroflavan to protect against rhinovirus infection in man |
| Q34321393 | Human rhinoviruses |
| Q36970004 | Phosphatidylinositol 4-kinase III beta is essential for replication of human rhinovirus and its inhibition causes a lethal phenotype in vivo |
| Q36944919 | Potential use of antiviral agents in polio eradication |
| Q30451364 | Prophylactic activity of intranasal enviroxime against experimentally induced rhinovirus type 39 infection |
| Q26798463 | Replication and Inhibitors of Enteroviruses and Parechoviruses |
| Q72379912 | Some further studies on the prediction of experimental colds in volunteers by psychological factors |
| Q28360293 | Studies on 44 081 R.P., a new antirhinovirus compound, in cell cultures and in volunteers |
| Q39870651 | The antiviral compound enviroxime targets the 3A coding region of rhinovirus and poliovirus. |
| Q69899882 | The common cold |
| Q37588593 | The human rhinovirus: human-pathological impact, mechanisms of antirhinoviral agents, and strategies for their discovery. |
| Q39499538 | The need for new antiviral agents |
| Q35742203 | Therapeutic activity of enviroxime against rhinovirus infection in volunteers |
| Q35761850 | Topical enviroxime against rhinovirus infection |
| Q38182376 | Transmission and control of rhinovirus colds |
| Q45269971 | Treatment of human enterovirus infections |
| Q28212435 | Treatment of picornavirus infections |
| Q33291075 | WITHDRAWN: Antivirals for the common cold |